BLACKROCK NORTH AMERICAN INCOME TRUST plc
All information is at 30 September 2014 and unaudited.
Performance at month end with net income reinvested
One Three Six Since
Month months months launch
(24 Oct 2012)
Net asset value 1.3% 5.5% 5.9% 26.9%
Share price 0.5% 1.0% 2.8% 16.1%
Russell 1000 Value Index 0.3% 5.3% 7.9% 43.8%
Source: BlackRock
At month end
Net asset value - capital only: 116.08p
Net asset value - cum income: 117.05p
Share price: 109.00p
Discount to cum income NAV: 6.9%
Net yield*: 3.7%
Total assets including current year revenue: £117.5m
Target annual dividend: 4.0p
Gearing: 1.9%
Options overwrite: 18.39%
Ordinary shares in issue: 100,361,305
Ongoing charges**: 1.4%
*Based on dividends of 1p per share each declared on 3 October 2013,
13 February 2014, 14 May 2014 and 6 August 2014.
** Ongoing charges represent the management fee and all other operating
expenses excluding interest as a % of average shareholders' funds for
the year ended 31 October 2013.
Benchmark
Sector Analysis Total Assets (%)
Financials 26.9
Industrials 15.0
Energy 12.2
Health Care 10.2
Consumer Discretionary 8.9
Information Technology 7.7
Consumer Staples 7.6
Materials 6.0
Utilities 5.2
Telecommunication Services 2.2
Net current liabilities (1.9)
-----
100.0
=====
Country Analysis Total Assets (%)
USA 96.1
Canada 2.1
France 1.4
United Kingdom 1.0
Australia 0.9
Netherlands 0.4
Net current liabilities (1.9)
-----
100.0
=====
Ten Largest Investments (in alphabetical order)
Company Country of Risk
Chevron USA
Comcast USA
General Electric USA
Home Depot USA
JPMorgan Chase USA
Merck USA
Microsoft USA
Pfizer USA
Raytheon USA
Wells Fargo USA
Bob Shearer, Tony DeSpirito and Kathleen Anderson representing the Investment
Manager, noted:
Performance
For the one month period ended 30 September 2014, the Company's NAV increased
by 1.3% and the share price increased by 0.5% (all in sterling). The Company's
benchmark, the Russell 1000 Value Index, increased by 0.3% for the period.
The largest contributor to relative performance was stock selection in the
industrials sector, as our overweight positions in the defence primes Raytheon,
Northrup Grumman, and Lockheed Martin benefited from geopolitical uncertainty.
This was followed by strong stock selection within the energy, consumer
discretionary and financials sectors. Additionally, stock selection in
information technology and materials added modestly to relative performance
for the period.
The largest detractor from relative performance for the month was stock
selection within consumer staples. Our underweight to health care also
detracted modestly from relative returns, as did stock selection in the
telecommunication services and utilities sectors.
Transactions/Options
Transactions: In September, we increased our financials exposure by adding to
existing positions in Bank of America and MetLife. Additionally, we increased
our health care exposure by initiating a position in Becton Dickinson.
Conversely, we reduced our exposure to consumer staples during the month by
selling out of Kimberly-Clark. We eliminated our position in Kimberly-Clark due
to concerns of increased competition in some of their key product segments.
As of 30 September 2014, the Company's options exposure was 18.39% and the
delta of the options was 94.63%.
Positioning
The Company is currently overweight to the industrials, materials, consumer
discretionary and consumer staples sectors. We are most underweight to the
financials, health care and information technology sectors. Despite relative
underweights to financials and information technology, we have increased our
exposure to these segments in recent months given stronger fundamentals, the
potential for dividend growth and attractive valuations.
Outlook
We remain constructive on the U.S. economy given improvements in U.S.
employment data and benign levels of inflation. Conversations with our
management teams and economic data points (consumer confidence, manufacturing,
etc.) continue to support our view that the U.S. economy is slowly gaining
strength. This economic improvement, the end of QE3, and ultimately Federal
action will likely cause interest rates (and volatility) to drift higher. As
the bounty of abundant liquidity is withdrawn, we expect profitable companies
with strong balance sheets, dominant competitive positions and consistent
earnings and dividend growth potential to outperform.
16 October 2014
ENDS
Latest information is available by typing www.blackrock.co.uk/brna on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.